医学检查与临床诊断

D-二聚体联合NT-proBNP对急性冠脉综合征患者发生肾功能不全的诊断价值

  • 范文璐 ,
  • 杜小宇 ,
  • 卢成志
展开
  • 1.天津医科大学一中心临床学院 (天津 300192 )
    2.中国人民解放军北京卫戍区东城第一离职干部休养所
    1.北京100120),天津市第一中心医院心内科,(天津 300192

收稿日期: 2024-11-22

  网络出版日期: 2025-03-20

基金资助

国家自然科学基金项目(81970303);天津市医学重点学科(专科)建设项目(TJYXZDXK-054B)

Diagnostic value of D⁃dimer combined with NT⁃proBNP in the occurrence of renal dysfunction in ACS patients

  • Wenlu FAN ,
  • Xiaoyu DU ,
  • Chengzhi. LU
Expand
  • *.The First Central Clinical School,Tianjin Medical University,Tianjin 300192,China
    *.The Chinese People's Liberation Army Beijing Garrison Dongcheng First Demobilized Cadres Rest,Beijing 100120,China

Received date: 2024-11-22

  Online published: 2025-03-20

摘要

目的 探讨D-二聚体(D-dimer, D-D)联合血浆氨基末端脑钠肽前体(N-terminal pro-B-type natriuretic peptide, NT-proBNP)对急性冠脉综合征(acute coronary syndrome, ACS)患者发生肾功能不全的临床诊断价值。 方法 本研究为回顾性队列研究,选取2021年1月至2023年12月在天津市第一中心医院胸痛中心就诊的ACS患者682例为研究对象。根据未行冠状动脉造影前的肌酐值计算的肾小球滤过率分为肾功能不全组和肾功能正常组,分别为102例和580例。采用二元logistic回归分析法分析ACS患者发生肾功能不全的影响因素,采用受试者工作特征曲线(receiver operator characteristic, ROC)评价D-D、NT-proBNP水平对ACS患者中发生肾功能不全的诊断价值。 结果 肾功能不全组的D-D、NT-proBNP水平显著高于肾功能正常组(P < 0.05);单因素logistic回归分析显示D-D、NT-proBNP水平升高均是ACS患者发生肾功能不全的独立危险因素。多因素logistic回归分析显示D-D联合NT-proBNP检测是ACS患者发生肾功能不全的独立危险因素。ROC结果显示,D-D水平诊断ACS患者发生肾功能不全的AUC为0.805,敏感度58.82%,特异度100%;NT-proBNP水平诊断ACS患者心肌梗死后发生肾功能不全的AUC为0.737,敏感度67.65%,特异度73.62%;D-D联合NT-proBNP诊断ACS患者发生肾功能不全的AUC为0.838,敏感度68.63%,特异度为93.28%。联合检测诊断价值优于各项单独检测。 结论 ACS患者中发生肾功能不全的D-D、NT-proBNP水平显著升高,是肾功能不全发生的独立危险因素,且联合检测有助于诊断肾功能不全。

本文引用格式

范文璐 , 杜小宇 , 卢成志 . D-二聚体联合NT-proBNP对急性冠脉综合征患者发生肾功能不全的诊断价值[J]. 实用医学杂志, 2025 , 41(5) : 736 -741 . DOI: 10.3969/j.issn.1006-5725.2025.05.018

Abstract

Objective The study aimed to explore the clinical diagnostic value of D?Dimer (D?D) combined with N?terminal pro?B?type natriuretic peptide(NT?proBNP) in the occurrence of renal dysfunction in patients with acute coronary syndrome (ACS). Methods As a retrospective cohort study, we selected 682 patients as the research subjects. The patients were with acute coronary syndrome who visited the Chest Pain Center of Tianjin First Central Hospital during January 2021 and December 2023. Based on the eGFR values calculated from the creatinine levels before coronary angiography, patients were divided into the renal insufficiency group and the normal renal function group, comprising 102 cases and 580 cases, respectively. Binary logistic regression was adopted to analyze the influence factors of renal dysfunction in ACS patients, and the receiver operating characteristic (ROC) curve was utilized to evaluate the diagnostic value of D?D and NT?proBNP levels for renal dysfunction in ACS patients. Results The levels of D?D and NT?proBNP in the renal insufficiency group were significantly higher than those in the normal renal function group (P < 0.05). Univariate logistic regression analysis showed that the rise of D?D and NT?proBNP levels were both independent risks for renal dysfunction in ACS patients. Multivariate logistic regression analysis indicated that the combined detection of D?D and NT?proBNP was an independent risk factor for renal dysfunction in ACS patients. The ROC results showed that the AUC, sensitivity, and specificity of the D?D level in diagnosing renal dysfunction in ACS patients were 0.805, 58.82%, and 100%, respectively. The AUC, sensitivity, and specificity of NT?proBNP level in diagnosing renal dysfunction after myocardial infarction in ACS patients were 0.737, 67.65%, and 73.62%, respectively. The AUC, sensitivity, and specificity of D?D combined with NT?proBNP in diagnosing renal dysfunction in ACS patients were 0.838, 68.63%, and 93.28%, respectively. The diagnostic value of combined detection was superior to that of individual testing. Conclusions The levels of D?D and NT?proBNP were significantly elevated in ACS patients with renal dysfunction, which were independent risk factors for the occurrence of renal dysfunction, and the combined detection could help diagnose renal dysfunction.

参考文献

1 国家心血管病中心. 中国心血管健康与疾病报告2023[M].北京: 北京协和医科大学出版社, 2024.
2 PANNONE L, FALASCONI G, CIANFANELLI L,et al. Sudden cardiac death in patients with heart diseasand preserved systolic function: current options for risk stratification[J]. J Clin Med, 2021, 10(9): 1823. doi:10.3390/jcm10091823
3 BARSTOW C. Acutecoronary syndrome:presentation and diagnostic evaluation[J].FP Essent,2020,490(1):11-19.
4 ATWOOD J. Management of Acute Coronary Syndrome[J]. Emerg Med Clin North Am, 2022, 40(4):693-706. doi:10.1016/j.emc.2022.06.008
5 FOREMAN K, MARQUEZ N, DOLGERT A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenariosfor2016-40 for195countries and territories[J]. Lancet, 2018,392(10159):2052-2090. doi:10.1016/s0140-6736(18)31694-5
6 MCDONAGH T A, METRA M, ADAMO M,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of theEuropeanSocietyofCardiology (ESC).With the special contribution of the HeartFailureAssociation(HFA)ofthe ESC[J].Eur J Heart Fail,2022,24(1):4-131. doi:10.1002/ejhf.2333
7 ZOCCALI C, MALLAMACI F, ADAMCZAK M, et al. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association[J]. Cardiovasc Res, 2023, 119(11):2017-2032. doi:10.1093/cvr/cvad083
8 MOISI M,RUS M, BUNGAU S,et al.Acute coronary syndromes in chronic kidney disease: clinical and therapeutic characteristics[J].Medicina,2020,56(3):118. doi:10.3390/medicina56030118
9 JIANG Y, ZHU Y, XIANG Z, et al. The prognostic value of admission D-dimer level in patients with cardiogenic shock after acute myocardial infarction[J]. Front Cardiovasc Med, 2023, 9:1083881. doi:10.3389/fcvm.2022.1083881
10 SHI J, WANG W, SUN Y, et al.Diagnostic Value of cTnl, NT-pro BNP, and Combined Tests in Acute Myocardial Infarction Patients[J]. Altern Ther Health Med, 2023, 29(7):412-417.
11 INKER L, ASTOR B,FOX C,et al.KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD[J].Am J Kidney Dis,2014,63(5):713-735. doi:10.1053/j.ajkd.2014.01.416
12 中国血脂管理指南(基层版 2024年)[J]. 中国循环杂志, 2024, 39(4): 313-327.
13 王询,傅向华.急性心肌梗死合并肾功能不全患者预测诊断与治疗的系列研究[D].石家庄:河北医科大学,2023.
14 陈如萍, 刘蕊, 孙遨, 等. 基于社区老年健康体检人群的慢性肾脏病流行病学调查[J]. 实用医学杂志, 2021, 37(13): 1755? 1760.
15 RUSSO J, GOODMAN S, CANTOR W, et al. Does renal function affect the efficacy or safety of a harmacoinvasive strategy in atients with ST-elevation myocardial infarction? A meta-analysis[J]. Am Heart, 2017, 193: 46-54. doi:10.1016/j.ahj.2017.07.015
16 刘梅, 莫曼秋, 谭琳, 等. 单中心急性肾损伤的短期预后调查分析[J]. 实用医学杂志, 2022, 38(1): 101-105.
17 DANIELE C, NARDOZI D, TORELLI A,et al.Transcutaneousmeasurement of glomerular filtration rate in rodents[J].Meth?ods Mol Biol,2020,2067:129?137. doi:10.1007/978-1-4939-9841-8_9
18 KOELLING E, JAZAERI O. An overview of renal insufficiency, race, and glomerular filtration rate calculation for the vascular surgeon[J]. Vasc Surg, 2022, 75(1):3-4. doi:10.1016/j.jvs.2021.10.023
19 HAN Q, ZHANG D, ZHAO Y,et al.The practicality of differenteGFR equations in centenarians and near?centenarians: Which equation shouldwe choose?[J].Peer J,2020,8:e8636. doi:10.7717/peerj.8636
20 FALSTER C, ANDERSEN N. Diagnostic accuracy of fibrin D-dimer[J].Ugeskr Laeger, 2022, 184(28) :V01220074.
21 DOMINGUETI C, DUSSE L, CARVALHO M, et al. Diabetes mellitus: the linkage between oxidativestress,inflammation, hypercoagulability and vascular complications[J]. Diabetes Complications, 2016, 30(4):738-745. doi:10.1016/j.jdiacomp.2015.12.018
22 FLUECKIGER S, RAVIOLI S, BUITRAGO-TELLEZ C,et al. Renal function-adapted D-dimer cutoffs in combination with a clinical prediction rule to exclude pulmonary embolism in patients presenting to the emergency department[J]. Intern Emerg Med, 2024, 19(5):1219-1227. doi:10.1007/s11739-023-03521-3
23 YU Y, ZHU C, LIN Y, et al.Plasma D-dimer levels are associated with disease progression in diabetic nephropathy: a two-center cohort study[J]. Ren Fail, 2023, 45(2):2285868. doi:10.1080/0886022x.2023.2285868
24 SEO M, LEE J. Low D-dimer in acute coronary syndrome and heart failure: Screening for large vessel diseases in patients with chest symptoms[J]. Heliyon, 2024, 10(10):e31210. doi:10.1016/j.heliyon.2024.e31210
25 BIDADKOSH A, LAMBOOY S, HEERSPINK H,et al.Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy[J].Diabetes Care,2017,40(6):784-792. doi:10.2337/dc16-2175
26 曾涛,王艳芳.冠脉介入治疗对冠心病急性心肌梗死患者心室重塑与NT-PROBNP的影响[J].医药论坛杂志,2019,40(5):63-65.
27 MCCALLUM W, SARNAK M. Cardiorenal Syndrome in the Hospital[J]. Clin J Am Soc Nephrol, 2023, 18(7):933-945. doi:10.2215/cjn.0000000000000064
28 张杰良,黄雪珍,邓文成.合并不同心血管疾病肾功能不全患者NT-proBNP与hs-TnT的临床检测[J]. 实用检验医师杂志,2020,12(3):143-146.
29 ECKRICH K, MANGNER N, ERBS S, et al.Baseline NT-proBNP predicts acute kidney injury following transcatheter aortic valve implantation[J]. Cardiovasc Revasc Med, 2024, 66:15-20. doi:10.1016/j.carrev.2024.03.027
文章导航

/